• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

适用于有限个体患者数据的兼容间接治疗比较的参数 G 计算。

Parametric G-computation for compatible indirect treatment comparisons with limited individual patient data.

机构信息

Department of Statistical Science, University College London, London, UK.

Quantitative Research, Statistical Outcomes Research & Analytics (SORA) Ltd, London, UK.

出版信息

Res Synth Methods. 2022 Nov;13(6):716-744. doi: 10.1002/jrsm.1565. Epub 2022 May 16.

DOI:10.1002/jrsm.1565
PMID:35485582
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9790405/
Abstract

Population adjustment methods such as matching-adjusted indirect comparison (MAIC) are increasingly used to compare marginal treatment effects when there are cross-trial differences in effect modifiers and limited patient-level data. MAIC is based on propensity score weighting, which is sensitive to poor covariate overlap and cannot extrapolate beyond the observed covariate space. Current outcome regression-based alternatives can extrapolate but target a conditional treatment effect that is incompatible in the indirect comparison. When adjusting for covariates, one must integrate or average the conditional estimate over the relevant population to recover a compatible marginal treatment effect. We propose a marginalization method based on parametric G-computation that can be easily applied where the outcome regression is a generalized linear model or a Cox model. The approach views the covariate adjustment regression as a nuisance model and separates its estimation from the evaluation of the marginal treatment effect of interest. The method can accommodate a Bayesian statistical framework, which naturally integrates the analysis into a probabilistic framework. A simulation study provides proof-of-principle and benchmarks the method's performance against MAIC and the conventional outcome regression. Parametric G-computation achieves more precise and more accurate estimates than MAIC, particularly when covariate overlap is poor, and yields unbiased marginal treatment effect estimates under no failures of assumptions. Furthermore, the marginalized regression-adjusted estimates provide greater precision and accuracy than the conditional estimates produced by the conventional outcome regression, which are systematically biased because the measure of effect is non-collapsible.

摘要

当存在试验间效应修饰因素的差异且患者水平数据有限时,人群调整方法(如调整后间接比较的匹配调整法)越来越多地用于比较边缘治疗效果。MAIC 基于倾向评分加权,该方法对协变量重叠不良敏感,并且无法外推至观察到的协变量空间之外。目前基于结果回归的替代方法可以外推,但针对的是间接比较中不兼容的条件治疗效果。在进行协变量调整时,必须在相关人群中对条件估计值进行积分或平均,以恢复兼容的边缘治疗效果。我们提出了一种基于参数 G 计算的边缘化方法,该方法可以在结果回归为广义线性模型或 Cox 模型的情况下轻松应用。该方法将协变量调整回归视为一种干扰模型,并将其估计与感兴趣的边缘治疗效果的评估分开。该方法可以适应贝叶斯统计框架,该框架将分析自然地集成到概率框架中。一项模拟研究提供了原理证明,并将该方法的性能与 MAIC 和常规结果回归进行了基准测试。参数 G 计算比 MAIC 更精确、更准确,尤其是在协变量重叠不良的情况下,并且在没有假设失败的情况下产生无偏的边缘治疗效果估计。此外,边缘化回归调整后的估计值比常规结果回归产生的条件估计值提供更高的精度和准确性,因为常规结果回归的效果衡量是不可 collapsible 的,因此会产生系统偏差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28de/9790405/75ca8b309cba/JRSM-13-716-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28de/9790405/bb50156fce31/JRSM-13-716-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28de/9790405/b323f8b4ba06/JRSM-13-716-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28de/9790405/33312490b846/JRSM-13-716-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28de/9790405/75ca8b309cba/JRSM-13-716-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28de/9790405/bb50156fce31/JRSM-13-716-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28de/9790405/b323f8b4ba06/JRSM-13-716-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28de/9790405/33312490b846/JRSM-13-716-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28de/9790405/75ca8b309cba/JRSM-13-716-g001.jpg

相似文献

1
Parametric G-computation for compatible indirect treatment comparisons with limited individual patient data.适用于有限个体患者数据的兼容间接治疗比较的参数 G 计算。
Res Synth Methods. 2022 Nov;13(6):716-744. doi: 10.1002/jrsm.1565. Epub 2022 May 16.
2
Model-based standardization using multiple imputation.基于模型的标准化方法:多重插补。
BMC Med Res Methodol. 2024 Feb 10;24(1):32. doi: 10.1186/s12874-024-02157-x.
3
Methods for population adjustment with limited access to individual patient data: A review and simulation study.利用有限的个体患者数据进行人群调整的方法:综述和模拟研究。
Res Synth Methods. 2021 Nov;12(6):750-775. doi: 10.1002/jrsm.1511. Epub 2021 Sep 5.
4
Two-stage matching-adjusted indirect comparison.两阶段匹配调整间接比较。
BMC Med Res Methodol. 2022 Aug 8;22(1):217. doi: 10.1186/s12874-022-01692-9.
5
Evaluation of Adjusted and Unadjusted Indirect Comparison Methods in Benefit Assessment. A Simulation Study for Time-to-event Endpoints.效益评估中调整和未调整间接比较方法的评价。一项针对事件发生时间终点的模拟研究。
Methods Inf Med. 2017 May 18;56(3):261-267. doi: 10.3414/ME15-02-0016. Epub 2017 Mar 31.
6
Assessing the performance of population adjustment methods for anchored indirect comparisons: A simulation study.评估用于锚定间接比较的总体调整方法的性能:一项模拟研究。
Stat Med. 2020 Dec 30;39(30):4885-4911. doi: 10.1002/sim.8759. Epub 2020 Oct 4.
7
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
8
The performance of different propensity score methods for estimating marginal hazard ratios.不同倾向评分方法估计边缘风险比的性能。
Stat Med. 2013 Jul 20;32(16):2837-49. doi: 10.1002/sim.5705. Epub 2012 Dec 12.
9
Comparative Efficacy and Safety of Ozanimod and Dimethyl Fumarate for Relapsing-Remitting Multiple Sclerosis Using Matching-Adjusted Indirect Comparison.基于匹配调整间接比较的奥扎尼莫德与富马酸二甲酯治疗复发缓解型多发性硬化症的疗效和安全性比较
CNS Drugs. 2021 Jul;35(7):795-804. doi: 10.1007/s40263-021-00805-0. Epub 2021 Apr 13.
10
The Effects of Model Misspecification in Unanchored Matching-Adjusted Indirect Comparison: Results of a Simulation Study.未锚定匹配调整间接比较中模型误设的影响:一项模拟研究的结果。
Value Health. 2020 Jun;23(6):751-759. doi: 10.1016/j.jval.2020.02.008. Epub 2020 May 4.

引用本文的文献

1
Matching-adjusted indirect comparison of selpercatinib and pralsetinib in fusion-positive non-small cell lung cancer.塞尔帕替尼与普拉替尼在融合阳性非小细胞肺癌中的匹配调整间接比较
Future Oncol. 2025 Jun;21(15):1867-1878. doi: 10.1080/14796694.2025.2508132. Epub 2025 Jun 3.
2
A Framework for Reliable, Transparent, and Reproducible Population-Adjusted Indirect Comparisons.一个用于可靠、透明和可重复的人群调整间接比较的框架。
Pharmacoeconomics. 2025 May 5. doi: 10.1007/s40273-025-01503-1.
3
Defining Biological and Clinical Plausibility: The DICSA Framework for Protocolized Assessment in Survival Extrapolations Across Therapeutic Areas.

本文引用的文献

1
Stan: A Probabilistic Programming Language.斯坦:一种概率编程语言。
J Stat Softw. 2017;76. doi: 10.18637/jss.v076.i01. Epub 2017 Jan 11.
2
Target estimands for population-adjusted indirect comparisons.人群校正间接比较的目标估计量。
Stat Med. 2022 Dec 10;41(28):5558-5569. doi: 10.1002/sim.9413.
3
Effect modification in anchored indirect treatment comparison: Comments on "Matching-adjusted indirect comparisons: Application to time-to-event data".锚定间接治疗比较中的效应修正:对《匹配调整间接比较:应用于事件发生时间数据》的评论
定义生物学和临床合理性:跨治疗领域生存外推中方案化评估的DICSA框架。
Pharmacoeconomics. 2025 Mar 29. doi: 10.1007/s40273-025-01485-0.
4
Model-based standardization using multiple imputation.基于模型的标准化方法:多重插补。
BMC Med Res Methodol. 2024 Feb 10;24(1):32. doi: 10.1186/s12874-024-02157-x.
5
Belimumab versus anifrolumab in adults with systemic lupus erythematosus: an indirect comparison of clinical response at 52 weeks.贝利尤单抗与阿尼鲁单抗治疗成人系统性红斑狼疮:52 周临床应答的间接比较。
Lupus Sci Med. 2023 May;10(1). doi: 10.1136/lupus-2023-000907.
6
Letter to the Editor: indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus.致编辑的信:阿尼鲁单抗与贝利尤单抗治疗成年系统性红斑狼疮疗效的间接治疗比较
J Comp Eff Res. 2023 Jan;12(1):e220106. doi: 10.2217/cer-2022-0106. Epub 2022 Dec 14.
7
Some considerations on target estimands for health technology assessment.关于卫生技术评估目标估计量的一些思考。
Stat Med. 2022 Dec 10;41(28):5592-5596. doi: 10.1002/sim.9566.
8
Two-stage matching-adjusted indirect comparison.两阶段匹配调整间接比较。
BMC Med Res Methodol. 2022 Aug 8;22(1):217. doi: 10.1186/s12874-022-01692-9.
Stat Med. 2022 Apr 15;41(8):1541-1553. doi: 10.1002/sim.9286.
4
Methods for population adjustment with limited access to individual patient data: A review and simulation study.利用有限的个体患者数据进行人群调整的方法:综述和模拟研究。
Res Synth Methods. 2021 Nov;12(6):750-775. doi: 10.1002/jrsm.1511. Epub 2021 Sep 5.
5
Target estimands for efficient decision making: Response to comments on "Assessing the performance of population adjustment methods for anchored indirect comparisons: A simulation study".用于高效决策的目标估计量:对《评估锚定间接比较中总体调整方法的性能:一项模拟研究》评论的回应
Stat Med. 2021 May 20;40(11):2759-2763. doi: 10.1002/sim.8965.
6
Conflating marginal and conditional treatment effects: Comments on "Assessing the performance of population adjustment methods for anchored indirect comparisons: A simulation study".混淆边际和条件处理效应:对“评估锚定间接比较的人群调整方法的性能:一项模拟研究”的评论。
Stat Med. 2021 May 20;40(11):2753-2758. doi: 10.1002/sim.8857.
7
Bayesian semi-parametric G-computation for causal inference in a cohort study with MNAR dropout and death.用于具有非随机缺失和死亡的队列研究中因果推断的贝叶斯半参数G计算法
J R Stat Soc Ser C Appl Stat. 2021 Mar;70(2):398-414. doi: 10.1111/rssc.12464. Epub 2021 Jan 6.
8
Making apples from oranges: Comparing noncollapsible effect estimators and their standard errors after adjustment for different covariate sets.将橘子变成苹果:比较在调整不同协变量集后不可折叠的效应估计量及其标准误差。
Biom J. 2021 Mar;63(3):528-557. doi: 10.1002/bimj.201900297. Epub 2020 Dec 14.
9
Alternative weighting schemes when performing matching-adjusted indirect comparisons.进行匹配调整间接比较时的替代加权方案。
Res Synth Methods. 2021 May;12(3):333-346. doi: 10.1002/jrsm.1466. Epub 2020 Dec 22.
10
Assessing the performance of population adjustment methods for anchored indirect comparisons: A simulation study.评估用于锚定间接比较的总体调整方法的性能:一项模拟研究。
Stat Med. 2020 Dec 30;39(30):4885-4911. doi: 10.1002/sim.8759. Epub 2020 Oct 4.